Amphastar Pharmaceuticals (AMPH) Free Cash Flow Growth (3y) (2016 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Free Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 14.41% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -10.40% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -47.39% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -30.54% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 49.35% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 43.55% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | -2.33% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | 16.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.33% |
| Mar 31, 2026 | 7.44% |
| Dec 31, 2025 | 40.24% |
| Sep 30, 2025 | 47.39% |
| Jun 30, 2025 | 127.09% |
| Mar 31, 2025 | -17.90% |
| Dec 31, 2024 | -20.90% |
| Sep 30, 2024 | 128.49% |
| Jun 30, 2024 | 33.65% |
| Mar 31, 2024 | 45.14% |
| Dec 31, 2023 | 24.00% |
| Sep 30, 2023 | 157.36% |
| Jun 30, 2023 | 33.68% |
| Mar 31, 2023 | 88.83% |
| Dec 31, 2022 | 73.61% |
| Sep 30, 2022 | 39.48% |
| Jun 30, 2022 | -27.27% |
| Mar 31, 2022 | 63.87% |
| Dec 31, 2021 | 703.30% |
| Sep 30, 2021 | -51.51% |